(ALCLS) - FDA

(ALCLS) – FDA

Dec 13, 2022 07:32 AM Cellectis (CLLS) Announces Positive Preliminary Clinical Data for UCART22 in ALL and UCART123 in AML
Aug 1, 2022 04:31 PM Cellectis (CLLS) Receives IND clearance for UCART20x22, its First in-house Manufactured Product Candidate for the Treatment of B-cell Malignancies
Nov 12, 2021 08:12 AM
Jul 6, 2020 04:33 PM
Nov 13, 2019 04:35 PM
Jul 8, 2019 04:31 PM
Apr 2, 2019 04:32 PM
Jun 4, 2018 04:31 PM
Nov 7, 2017 06:38 AM
Aug 17, 2017 04:35 PM
Jul 24, 2017 04:34 PM
Mar 9, 2017 06:29 AM
Feb 6, 2017 04:32 PM
Jan 3, 2017 05:02 PM
Dec 15, 2016 05:18 PM
Jun 20, 2016 05:05 PM
May 2, 2016 05:28 PM
Mar 16, 2016 05:03 PM